- Home
- MDWD vs TDUP Comparison
MDWD vs TDUP Comparison
Compare MDWD & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDWD
- TDUP
- Stock Information
- Founded
- MDWD 2000
- TDUP 2009
- Country
- MDWD Israel
- TDUP United States
- Employees
- MDWD N/A
- TDUP N/A
- Industry
- MDWD Medicinal Chemicals and Botanical Products
- TDUP Catalog/Specialty Distribution
- Sector
- MDWD Health Care
- TDUP Consumer Discretionary
- Exchange
- MDWD Nasdaq
- TDUP Nasdaq
- Market Cap
- MDWD 184.8M
- TDUP 172.9M
- IPO Year
- MDWD 2014
- TDUP 2021
- Fundamental
- Price
- MDWD $17.75
- TDUP $1.48
- Analyst Decision
- MDWD Strong Buy
- TDUP Buy
- Analyst Count
- MDWD 1
- TDUP 6
- Target Price
- MDWD $25.00
- TDUP $3.40
- AVG Volume (30 Days)
- MDWD 56.9K
- TDUP 444.8K
- Earning Date
- MDWD 11-26-2024
- TDUP 03-03-2025
- Dividend Yield
- MDWD N/A
- TDUP N/A
- EPS Growth
- MDWD N/A
- TDUP N/A
- EPS
- MDWD N/A
- TDUP N/A
- Revenue
- MDWD $19,720,000.00
- TDUP $313,757,000.00
- Revenue This Year
- MDWD $10.37
- TDUP N/A
- Revenue Next Year
- MDWD $26.36
- TDUP N/A
- P/E Ratio
- MDWD N/A
- TDUP N/A
- Revenue Growth
- MDWD N/A
- TDUP 0.58
- 52 Week Low
- MDWD $11.04
- TDUP $0.50
- 52 Week High
- MDWD $24.00
- TDUP $2.42
- Technical
- Relative Strength Index (RSI)
- MDWD 53.40
- TDUP 52.53
- Support Level
- MDWD $17.33
- TDUP $1.30
- Resistance Level
- MDWD $18.25
- TDUP $1.49
- Average True Range (ATR)
- MDWD 0.75
- TDUP 0.12
- MACD
- MDWD 0.05
- TDUP -0.02
- Stochastic Oscillator
- MDWD 73.68
- TDUP 62.71
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.